Hypertension Flashcards
(44 cards)
Atenolol
B1 receptor antagonist
B1 and B2: propranolol, B1: metoprolol, atenolol
• Mechanism of action:
– Non-selective B1- B2 or selective
Metoprolol
B receptor antagonist
B1 and B2: propranolol, B1: metoprolol, atenolol
• Mechanism of action:
– Non-selective B1- B2 or selective
Propranolol
B receptor antagonist
B1 and B2: propranolol, B1: metoprolol, atenolol
• Mechanism of action:
– Non-selective B1- B2 or selective
Doxazosin
alpha1 receptor antagonist
Mechanism of action:
– Blockade of
Prazosin
alpha receptor antagonist
Mechanism of action:
– Blockade of a1-receptors on VSM
– Dilation of arterioles and capacitance veins
• Use: alone or in combination for hypertension
– Pheochromocytoma
• Side/adverse effects:
– Reflex tachycardia, orthostatic hypotension, fluid
retention
– GI upset, palpitation, tinnitus, headache, dizziness,
urinary incontinence
– Water retention-use with diuretic or a-antagonist
Terazosin
alpha receptor antagonist
Mechanism of action:
– Blockade of a1-receptors on VSM
– Dilation of arterioles and capacitance veins
• Use: alone or in combination for hypertension
– Pheochromocytoma
• Side/adverse effects:
– Reflex tachycardia, orthostatic hypotension, fluid
retention
– GI upset, palpitation, tinnitus, headache, dizziness,
urinary incontinence
– Water retention-use with diuretic or a-antagonist
carvedilol
Mixed a/b antagonist
non-selective B and a1 receptor
antagonist
– Antioxidant and antiproliferative
• Use: hypertension and heart failure
Labetalol
Mixed a/b antagonist
non-selective B and a1 receptor
antagonist, mix of four stereoisomers
• Use: chronic hypertension and hypertensive
emergencies
reserpine
Inhibitor of peripheral transmission
Mechanism of action:
– Deplete NE from adrenergic nerve endings
– Inhibits reuptake of NE into storage terminal
– Decrease peripheral resistance and CO
• Use: mild to moderate hypertension
resurgence in use low dose in combination with
thiazide diuretic
• Adverse effects:
– Postural hypotension
– Sedation, dry mouth, nightmares
– Sodium and water retention-add diuretic
alpha-methyldopa
Central mediated agent
Brainstem a2 receptor
Mechanism of action:
– Stimulate brainstem a2 adrenergic receptors
• decrease sympathetic outflow
– Vagal activity to heart increased
– Decreased peripheral vascular resistance and CO
• Use: resistant hypertension-clonidine
– Pregnancy-induced hypertension-methyldopa
• Side/adverse effects:
– Withdrawal syndrome-rebound hypertension
– Sedation, dry mouth, depression, drowsiness
– Sodium and water retention-add diuretic
– Postural hypotension-elderly
clonidine
CNS mediated agent
Mechanism of action:
– Stimulate brainstem a2 adrenergic receptors
• decrease sympathetic outflow
– Vagal activity to heart increased
– Decreased peripheral vascular resistance and CO
• Use: resistant hypertension-clonidine
– Pregnancy-induced hypertension-methyldopa
• Side/adverse effects:
– Withdrawal syndrome-rebound hypertension
– Sedation, dry mouth, depression, drowsiness
– Sodium and water retention-add diuretic
– Postural hypotension-elderly
Guanabenz
CNS mediated agent
Mechanism of action:
– Stimulate brainstem a2 adrenergic receptors
• decrease sympathetic outflow
– Vagal activity to heart increased
– Decreased peripheral vascular resistance and CO
• Use: resistant hypertension-clonidine
– Pregnancy-induced hypertension-methyldopa
• Side/adverse effects:
– Withdrawal syndrome-rebound hypertension
– Sedation, dry mouth, depression, drowsiness
– Sodium and water retention-add diuretic
– Postural hypotension-elderly
Captopril
ACE inhibitor
Mechanism of action:
– Block conversion of angiotensin I to angiotensin II
– Elevate bradykinin levels
– Decreased peripheral resistance
– Decreased aldosterone- increase Na+ and
H2O excretion
– Reverse or reduce CV remodeling
– Increase plasma renin and renin activity
Adverse/toxic effects: – Dry cough (20%) and altered taste – Hyperkalemia-due to inhibition of aldosterone secretion – Angioedema – Hypotension – Rash – Pregnancy problems (fetal renal damage
Enalapril
ACE inhibitor
Mechanism of action:
– Block conversion of angiotensin I to angiotensin II
– Elevate bradykinin levels
– Decreased peripheral resistance
– Decreased aldosterone- increase Na+ and
H2O excretion
– Reverse or reduce CV remodeling
– Increase plasma renin and renin activity
Adverse/toxic effects: – Dry cough (20%) and altered taste – Hyperkalemia-due to inhibition of aldosterone secretion – Angioedema – Hypotension – Rash – Pregnancy problems (fetal renal damage
Fosinopril
ACE inhibitor
Mechanism of action:
– Block conversion of angiotensin I to angiotensin II
– Elevate bradykinin levels
– Decreased peripheral resistance
– Decreased aldosterone- increase Na+ and
H2O excretion
– Reverse or reduce CV remodeling
– Increase plasma renin and renin activity
Adverse/toxic effects: – Dry cough (20%) and altered taste – Hyperkalemia-due to inhibition of aldosterone secretion – Angioedema – Hypotension – Rash – Pregnancy problems (fetal renal damage
Lisinopril
ACE inhibitor
Mechanism of action:
– Block conversion of angiotensin I to angiotensin II
– Elevate bradykinin levels
– Decreased peripheral resistance
– Decreased aldosterone- increase Na+ and
H2O excretion
– Reverse or reduce CV remodeling
– Increase plasma renin and renin activity
Adverse/toxic effects: – Dry cough (20%) and altered taste – Hyperkalemia-due to inhibition of aldosterone secretion – Angioedema – Hypotension – Rash – Pregnancy problems (fetal renal damage
Candesartan
ARB
Mechanism of action: – AT1 receptor antagonists – Vasodilation – Increase Na+ and H2O excretion – Reduce plasma volume – Decrease cellular hypertrophy – Increase plasma renin and renin activity
Adverse/toxic effects: – Hypotension – NO cough or angioedema – Hyperkalemia – Fetal renal toxicity
irbesartan
ARB
Mechanism of action: – AT1 receptor antagonists – Vasodilation – Increase Na+ and H2O excretion – Reduce plasma volume – Decrease cellular hypertrophy – Increase plasma renin and renin activity
Adverse/toxic effects: – Hypotension – NO cough or angioedema – Hyperkalemia – Fetal renal toxicity
Losartan
ARB
Mechanism of action: – AT1 receptor antagonists – Vasodilation – Increase Na+ and H2O excretion – Reduce plasma volume – Decrease cellular hypertrophy – Increase plasma renin and renin activity
Adverse/toxic effects: – Hypotension – NO cough or angioedema – Hyperkalemia – Fetal renal toxicity
Valsartan
ARB
Mechanism of action: – AT1 receptor antagonists – Vasodilation – Increase Na+ and H2O excretion – Reduce plasma volume – Decrease cellular hypertrophy – Increase plasma renin and renin activity
Adverse/toxic effects: – Hypotension – NO cough or angioedema – Hyperkalemia – Fetal renal toxicity
Aliskiren
Renin Inhibitor
Mechanism of action:
– Direct, competitive inhibitor of renin
– Increase plasma renin but not renin activity
• Use: hypertension
– Not first line since long term CV outcomes unclear
• Side/adverse effects:
– Diabetic or renal impairment: hyperkalemia in combo with
ACEIs and ARBs
– Hypotension
– Dry cough but much less than with ACE inhibitors
– Rare: angioedema
– Hyperkalemia due to inhibition of aldosterone
Ambrisentan
Vasodilator
Mechanism of action:
– Direct dilators of VSM-different mechanisms
– Decrease peripheral vascular resistance
– Baroreceptor activation of compensatory mechanisms
• Use:
– Hypertension-hydralazine and minoxidil
– Hypertensive crises-nitroprusside
– Pulmonary hypertension-epoprostenol, bosentan,
ambrisentan, riociguat
– Used in combination-diuretics and B-antagonists
ETa receptor blocker:
Use: primary pulmonary hypertension • Side/adverse effects: – Edema – Headache – Spermatogenesis inhibition – Respiratory tract infection – Decreased hematocrit – Hepatic effects
Bosentan
Vasodilator
Mechanism of action:
– Direct dilators of VSM-different mechanisms
– Decrease peripheral vascular resistance
– Baroreceptor activation of compensatory mechanisms
• Use:
– Hypertension-hydralazine and minoxidil
– Hypertensive crises-nitroprusside
– Pulmonary hypertension-epoprostenol, bosentan,
ambrisentan, riociguat
– Used in combination-diuretics and B-antagonists
Non-selective ET receptor blocker
Use: primary pulmonary hypertension • Side/adverse effects: – Edema – Headache – Spermatogenesis inhibition – Respiratory tract infection – Decreased hematocrit – Hepatic effects
epoprostenol
Vasodilator
Mechanism of action:
– Direct dilators of VSM-different mechanisms
– Decrease peripheral vascular resistance
– Baroreceptor activation of compensatory mechanisms
• Use:
– Hypertension-hydralazine and minoxidil
– Hypertensive crises-nitroprusside
– Pulmonary hypertension-epoprostenol, bosentan,
ambrisentan, riociguat
– Used in combination-diuretics and B-antagonists
Prostacyclin (PGI2 ) • Mechanism of action: – Direct vasodilator via cAMP – Counteracts thromboxane A2 • Use: potent antihypertensive but must be administered continuously – Primary pulmonary hypertension